Screener
Vertex Pharmaceuticals VRTX Enterprise value
Enterprise value at other companies
Other financials
Where this comes from
Calculated from Vertex Pharmaceuticals’s reported figures.
The source filing: Vertex Pharmaceuticals’s 8-K, filed August 3, 2026. Open the filing →
- Filed
- Aug 3, 2026, 4:09 PM EDT
- Accession
- 0000875320-26-000256
FAQ
- What is Vertex Pharmaceuticals's enterprise value?
- Vertex Pharmaceuticals (VRTX) reported enterprise value of $120.2B in Q2 2026.
- How has Vertex Pharmaceuticals's enterprise value changed year-over-year?
- Vertex Pharmaceuticals's enterprise value increased by 7.2% year-over-year, from $112.17B to $120.2B.
- What is the long-term trend for Vertex Pharmaceuticals's enterprise value?
- Over 5 years (2020 to 2025), Vertex Pharmaceuticals's enterprise value has grown at a 14.0% compound annual growth rate (CAGR), from $58.23B to $111.97B.
- What does enterprise value mean?
- Market capitalization plus total debt minus cash, at the quarter end. The cost to acquire the whole business — what an buyer pays for equity and debt, net of the cash they'd inherit.
Ask your AI about Vertex Pharmaceuticals's enterprise value.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude